MENU
LYRA
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Lyra Therapeutics (LYRA) Ownership - Who owns Lyra Therapeutics?
Profile
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 393-4600
Employees
145
Web
https://lyratherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
17.39M
P/E Ratio
N/A
Total Cash
67.5M
Projected Growth
N/A
Total Debt
36.75M
Revenue
1.82M
Risk (Beta)
-0.32
Dividend Yield
N/A
Total Cash/Share
1.03
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price
Fundamentals
LYRA
Capitalization
17.4M
P/E Ratio
N/A
Risk (Beta)
-0.32
Dividend Yield
N/A
Total Cash
67.5M
Total Cash/Share
1.03
Total Debt
36.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
1.82M
ROE
N/A
Book Value
31M
P/B Ratio
0.55
Cash Flow
N/A
Earnings
-1.56
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
65K
Current Ratio
3.60
Current Revenue Per Employee
7475.00
Dividends Per Share - Security
N/A
EBITDA
-74.34M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-92.07
Shares Held By Institutions
46.7M
Shares Outstanding - Current
65.5M
Total Liabilities
63.6M
Total Volume MTD
N/A
Value
1
Gain YTD
-95.191
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage therapeutics company, which develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 393-4600
Employees
145
Web
https://lyratherapeutics.com